Detalles de la búsqueda
1.
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy.
J Med Chem
; 65(3): 1770-1785, 2022 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34494428
2.
Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1.
ACS Med Chem Lett
; 12(2): 288-294, 2021 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33603977
3.
Oral Delivery of Highly Lipophilic, Poorly Water-Soluble Drugs: Self-Emulsifying Drug Delivery Systems to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a Cholesteryl Ester Transfer Protein Inhibitor in Preclinical Species.
J Pharm Sci
; 107(5): 1352-1360, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29317226
4.
Sublimation characterization and vapor pressure estimation of an HIV nonnucleoside reverse transcriptase inhibitor using thermogravimetric analysis.
AAPS PharmSciTech
; 4(2): E23, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12916905
5.
Small molecule antagonist of leukocyte function associated antigen-1 (LFA-1): structure-activity relationships leading to the identification of 6-((5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic acid (BMS-688521).
J Med Chem
; 53(9): 3814-30, 2010 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-20405922
Resultados
1 -
5
de 5
1
Próxima >
>>